Published in J Immunol on October 01, 1997
Dried blood spots as a source of anti-malarial antibodies for epidemiological studies. Malar J (2008) 3.02
IgG subclasses and allotypes: from structure to effector functions. Front Immunol (2014) 1.95
IgG4 breaking the rules. Immunology (2002) 1.93
Bispecific Anti-HIV-1 Antibodies with Enhanced Breadth and Potency. Cell (2016) 1.84
Identification of IgF, a hinge-region-containing Ig class, and IgD in Xenopus tropicalis. Proc Natl Acad Sci U S A (2006) 1.29
Relationship of HIV-1 and SIV envelope glycoprotein trimer occupation and neutralization. Virology (2008) 1.26
Antibody 2G12 recognizes di-mannose equivalently in domain- and nondomain-exchanged forms but only binds the HIV-1 glycan shield if domain exchanged. J Virol (2010) 1.23
A Temporal Model of Human IgE and IgG Antibody Function. Front Immunol (2013) 1.23
Human immunoglobulin G2 (IgG2) and IgG4, but not IgG1 or IgG3, protect mice against Cryptococcus neoformans infection. Infect Immun (2007) 1.17
A synthetic trivalent hapten that aggregates anti-2,4-DNP IgG into bicyclic trimers. J Am Chem Soc (2007) 1.13
Rhesus macaque antibody molecules: sequences and heterogeneity of alpha and gamma constant regions. Immunology (2004) 1.13
Increased aggregation propensity of IgG2 subclass over IgG1: role of conformational changes and covalent character in isolated aggregates. Protein Sci (2010) 1.00
Human cytomegalovirus Fcγ binding proteins gp34 and gp68 antagonize Fcγ receptors I, II and III. PLoS Pathog (2014) 1.00
A preliminary analysis of the immunoglobulin genes in the African elephant (Loxodonta africana). PLoS One (2011) 0.90
Functional analysis of the anti-adalimumab response using patient-derived monoclonal antibodies. J Biol Chem (2014) 0.90
Human IgG isotypes and activating Fcγ receptors in the interaction of Salmonella enterica serovar Typhimurium with phagocytic cells. Immunology (2011) 0.89
In-depth analysis of subclass-specific conformational preferences of IgG antibodies. IUCrJ (2015) 0.89
Engineering an improved IgG4 molecule with reduced disulfide bond heterogeneity and increased Fab domain thermal stability. J Biol Chem (2012) 0.89
Hinge-Region O-Glycosylation of Human Immunoglobulin G3 (IgG3). Mol Cell Proteomics (2015) 0.88
Solution conformation of wild-type and mutant IgG3 and IgG4 immunoglobulins using crystallohydrodynamics: possible implications for complement activation. Biophys J (2007) 0.87
Antibody binding to Cryptococcus neoformans impairs budding by altering capsular mechanical properties. J Immunol (2012) 0.87
Molecular dynamics of hinge-bending motion of IgG vanishing with hydrolysis by papain. Biophys J (2000) 0.86
Chimeric antibodies to proteinase 3 of IgG1 and IgG3 subclasses induce different magnitudes of functional responses in neutrophils. Ann Rheum Dis (2007) 0.86
Disabling TNF receptor signaling by induced conformational perturbation of tryptophan-107. Proc Natl Acad Sci U S A (2005) 0.86
The structure of dual-variable-domain immunoglobulin molecules alone and bound to antigen. MAbs (2013) 0.85
Activation of complement by human IgG1 and human IgG3 antibodies against the human leucocyte antigen CD52. Immunology (1998) 0.84
Natural form of noncytolytic flexible human Fc as a long-acting carrier of agonistic ligand, erythropoietin. PLoS One (2011) 0.84
Time-resolved FRET -based approach for antibody detection - a new serodiagnostic concept. PLoS One (2013) 0.84
2G12-expressing B cell lines may aid in HIV carbohydrate vaccine design strategies. J Virol (2012) 0.83
Crystallohydrodynamics of protein assemblies: Combining sedimentation, viscometry, and x-ray scattering. Biophys J (2006) 0.82
IgG subclass co-expression brings harmony to the quartet model of murine IgG function. Immunol Cell Biol (2016) 0.82
The role of Fc receptors in HIV prevention and therapy. Immunol Rev (2015) 0.81
The solution structures of two human IgG1 antibodies show conformational stability and accommodate their C1q and FcγR ligands. J Biol Chem (2015) 0.81
Construction and functional activities of chimeric mouse-human immunoglobulin G and immunoglobulin M antibodies against the Neisseria meningitidis PorA P1.7 and P1.16 epitopes. Infect Immun (2003) 0.79
Non-antigen-contacting region of an asymmetric bispecific antibody to factors IXa/X significantly affects factor VIII-mimetic activity. MAbs (2015) 0.79
IgG4 Characteristics and Functions in Cancer Immunity. Curr Allergy Asthma Rep (2016) 0.79
Human IgG1, IgG3, and IgG3 Hinge-Truncated Mutants Show Different Protection Capabilities against Meningococci Depending on the Target Antigen and Epitope Specificity. Clin Vaccine Immunol (2016) 0.78
Three-dimensional structure of the human myeloma IgG2. PLoS One (2013) 0.78
On the perplexingly low rate of transport of IgG2 across the human placenta. PLoS One (2014) 0.77
Immune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodies. Biochim Biophys Acta (2016) 0.76
High-throughput sequencing of human immunoglobulin variable regions with subtype identification. PLoS One (2014) 0.76
Investigating Structure and Dynamics of Proteins in Amorphous Phases Using Neutron Scattering. Comput Struct Biotechnol J (2016) 0.75
Determining antibody stoichiometry using time-integrated fluorescence cumulant analysis. J Phys Chem B (2010) 0.75
Igg Subclasses Targeting the Flagella of Salmonella enterica Serovar Typhimurium Can Mediate Phagocytosis and Bacterial Killing. J Vaccines Vaccin (2016) 0.75
Reformatting Rituximab into Human IgG2 and IgG4 Isotypes Dramatically Improves Apoptosis Induction In Vitro. PLoS One (2015) 0.75
Variability of the inhibition by total immunoglobulin of in vitro autoantibody-mediated erythrophagocytosis by mouse macrophages. Clin Exp Immunol (2006) 0.75
Structural characterization of the Man5 glycoform of human IgG3 Fc. Mol Immunol (2017) 0.75
Human lymphocytes with receptors for IgG. A population of cells distinct from T- and B-lymphocytes. Int Arch Allergy Appl Immunol (1974) 2.39
Antigenic and chemical characterization of non-immunoglobulin amyloid proteins. Scand J Immunol (1972) 1.97
Detection of pathogenic Yersinia enterocolitica in foods and water by immunomagnetic separation, nested polymerase chain reactions, and colorimetric detection of amplified DNA. Appl Environ Microbiol (1993) 1.91
Isolation and characterization of amyloid-related serum protein SAA as a low molecular weight protein. Scand J Immunol (1975) 1.89
Primary structure of the "hinge" region of human IgG3. Probable quadruplication of a 15-amino acid residue basic unit. J Biol Chem (1977) 1.83
Antibody-dependent cytotoxicity mediated by human Fc-receptor-bearing cells lacking markers for B- and T-lymphocytes. Int Arch Allergy Appl Immunol (1974) 1.77
Evidence of similar idiotypic determinants on different rheumatoid factor populations. Scand J Immunol (1979) 1.74
Binding of aggregated IgG BY HUMAN B lymphocytes independent of Fc receptors. Scand J Immunol (1974) 1.44
Structural analysis of the nurse shark (new) antigen receptor (NAR): molecular convergence of NAR and unusual mammalian immunoglobulins. Proc Natl Acad Sci U S A (1998) 1.42
Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans. Infect Immun (1998) 1.42
Amyloid fibril protein subunit, "protein AS": distribution in tissue and serum in different clinical types of amyloidosis including that associated with myelomatosis and Waldenström's macroglobulinamia. Scand J Immunol (1973) 1.41
High-density lipoprotein as carrier for amyloid-related protein SAA in rabbit serum. Scand J Immunol (1979) 1.41
Inhibition of antibody-dependent human lymphocyte-mediated cytotoxicity by immunoglobulin classes, IgG subclasses, and IgG fragments. Scand J Immunol (1974) 1.41
Lack of suppressor cell activity in rheumatoid synovial lymphocytes. Scand J Immunol (1979) 1.36
Identification and characterization of different amyloid fibril proteins in tissue sections. Scand J Immunol (1977) 1.33
Unique amyloid protein subunit common to different types of amyloid fibril. Nature (1973) 1.30
Same idiotype of B-lymphocyte membrane IgD and IgM. Formal evidence for monoclonality of chronic lymphocytic leukemia cells. Scand J Immunol (1974) 1.29
Human T-cell responses after vaccination with the Norwegian group B meningococcal outer membrane vesicle vaccine. Infect Immun (1998) 1.27
Neurosyphilis: intrathecal synthesis of oligoclonal antibodies to Treponema pallidum. Ann Neurol (1982) 1.19
Characterization of subpopulations of human lymphoid cells participating in phytohemagglutinin and concanavalin A-induced cytotoxicity. Int Arch Allergy Appl Immunol (1974) 1.19
Human opsonins induced during meningococcal disease recognize outer membrane proteins PorA and PorB. Infect Immun (1999) 1.17
Human immunoglobulin G subclass immune response to outer membrane antigens in meningococcal group B vaccine. J Clin Microbiol (1987) 1.17
Shared idiotypes of human peripheral blood B and T lymphocytes. J Immunol (1979) 1.16
Lysine 322 in the human IgG3 C(H)2 domain is crucial for antibody dependent complement activation. Mol Immunol (2000) 1.14
Specificity of receptors for IgG on human lymphocyte-like cells. Scand J Immunol (1974) 1.13
Versatile vectors for transient and stable expression of recombinant antibody molecules in mammalian cells. J Immunol Methods (1997) 1.12
Opsonophagocytic activity induced by chimeric antibodies of the four human IgG subclasses with or without help from complement. Scand J Immunol (1994) 1.10
Three new fragments, F(ab) 2 , F(c) 2 , and Fab-c, obtained by papain proteolysis of normal human IgG. Scand J Immunol (1972) 1.10
Comparison among opsonic activity, antimeningococcal immunoglobulin G response, and serum bactericidal activity against meningococci in sera from vaccinees after immunization with a serogroup B outer membrane vesicle vaccine. Infect Immun (1995) 1.10
The structural requirements for complement activation by IgG: does it hinge on the hinge? Immunol Today (1995) 1.07
Structural requirements in the Fc region of rabbit IgG antibodies necessary to induce cytotoxicity by human lymphocytes. Scand J Immunol (1975) 1.06
The influence of the hinge region length in binding of human IgG to human Fcgamma receptors. Hum Immunol (1998) 1.05
Comparisons of the ability of human IgG3 hinge mutants, IgM, IgE, and IgA2, to form small immune complexes: a role for flexibility and geometry. J Immunol (1998) 1.05
Comparison of functional immune responses in humans after intranasal and intramuscular immunisations with outer membrane vesicle vaccines against group B meningococcal disease. Vaccine (2003) 1.02
Unusual molecular properties of human IgG3 proteins due to an extended hinge region. J Biol Chem (1974) 1.00
Alternative, non-immunoglobulin origin of amyloid fibrils. Nat New Biol (1972) 0.98
A comparison of human and murine monoclonal IgGs specific for the P1.7 PorA protein of Neisseria meningitidis. Mol Immunol (1994) 0.97
Functional activities and epitope specificity of human and murine antibodies against the class 4 outer membrane protein (Rmp) of Neisseria meningitidis. Infect Immun (1999) 0.97
Cross-idiotypic reactions among anti-Rh (D) antibodies. Scand J Immunol (1977) 0.96
IgG subclass distribution of serum antibodies against lipopolysaccharide from Bacteroides gingivalis in periodontal health and disease. Acta Pathol Microbiol Immunol Scand C (1987) 0.96
The binding parameters of radiolabelled monoclonal F (ab')2 and Fab' fragments relative to immunoglobulin G in reactions with surface-bound antigens. Eur J Nucl Med (1992) 0.96
The IgG subclass pattern of complement activation depends on epitope density and antibody and complement concentration. Scand J Immunol (1989) 0.95
Effect of streptolysin O and digitonin on egg lecithin/cholesterol vesicles. Biochim Biophys Acta (1980) 0.94
Structural requirements for incorporation of J chain into human IgM and IgA. Int Immunol (2000) 0.94
Specificity of rheumatoid factors cross-reacting with human and rabbit IgG. Acta Pathol Microbiol Scand B Microbiol Immunol (1974) 0.92
Respiratory Marburg virus infection in guinea pigs. Arch Virol (1996) 0.92
Polymerization of IgA and IgM: roles of Cys309/Cys414 and the secretory tailpiece. J Immunol (1999) 0.90
A low serum concentration of mannan-binding protein is not associated with serogroup B or C meningococcal disease. Scand J Immunol (1993) 0.90
Opsonophagocytic and bactericidal activity mediated by purified IgG subclass antibodies after vaccination with the Norwegian group B meningococcal vaccine. Scand J Immunol (1998) 0.90
Inhibition of complement-mediated red cell lysis by immunoglobulins is dependent on the IG isotype and its C1 binding properties. Scand J Immunol (1995) 0.89
Isolation of a fragment, Fh, corresponding to the hinge region of human IgG3. Scand J Immunol (1974) 0.89
Polysaccharides from the roots of Entada africana Guill. et Perr., Mimosaceae, with complement fixing activity. J Ethnopharmacol (2001) 0.89
SCID-Hu mice immunized with a pneumococcal vaccine produce specific human antibodies and show increased resistance to infection. Infect Immun (1992) 0.88
Human IgG3 can adopt the disulfide bond pattern characteristic for IgG1 without resembling it in complement mediated cell lysis. Mol Immunol (1993) 0.88
Towards a nasal vaccine against meningococcal disease, and prospects for its use as a mucosal adjuvant. Dev Biol Stand (1998) 0.88
Sterically stabilized liposomes as a carrier for alpha-emitting radium and actinium radionuclides. Nucl Med Biol (2004) 0.87
A transient monoclonal human IgG1 kappa protein with anti-thyroglobulin activity: lack of cross-idiotypy with polyclonal anti-thyroglobulin antibodies. Clin Exp Immunol (1981) 0.87
Characterization of subclass-related F(ab)2, Fab-c and Fch fragments obtainined by short papain digestion of human IgG myeloma proteins. Scand J Immunol (1973) 0.87
Quantitation of IgG subclass antibody responses after immunization with a group B meningococcal outer membrane vesicle vaccine, using monoclonal mouse-human chimeric antibodies as standards. J Immunol Methods (1996) 0.87
Effect of the IgM and IgA secretory tailpieces on polymerization and secretion of IgM and IgG. J Immunol (1996) 0.87
Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine. Dev Biol Stand (1998) 0.86
Antigen-specific T-cell responses in humans after intranasal immunization with a meningococcal serogroup B outer membrane vesicle vaccine. Infect Immun (1999) 0.86
Binding site and subclass specificity of the herpes simplex virus type 1-induced Fc receptor. Immunology (1985) 0.85
Antigenic studies of a VH fragment: demonstration of three sets of antigens, idiotypic, VH subgroup, and VH framework-specific antigens. J Immunol (1977) 0.85
Chimeric mouse human IgG3 antibodies with an IgG4-like hinge region induce complement-mediated lysis more efficiently than IgG3 with normal hinge. Eur J Immunol (1991) 0.85
The hinge region of IgG3, an extended part of the molecule. FEBS Lett (1972) 0.85
Sheep, rabbit and chicken antisera against a human VH fragment: reactivity with immunoglobulins and lymphocytes. Immunology (1982) 0.85
A high molecular weight serum protein is the carrier for amyloid-related protein SAA. Scand J Immunol (1977) 0.85
Vaccine-induced IgG antibodies to the linear epitope on the PorB outer membrane protein promote opsonophagocytosis of Neisseria meningitidis by human neutrophils. Clin Immunol Immunopathol (1997) 0.85
Activation of complement by an IgG molecule without a genetic hinge. Nature (1993) 0.84
Serum C-reactive protein in systemic infections due to Neisseria meningitidis. NIPH Ann (1986) 0.84
The principle of delivery of T cell epitopes to antigen-presenting cells applied to peptides from influenza virus, ovalbumin, and hen egg lysozyme: implications for peptide vaccination. Proc Natl Acad Sci U S A (2001) 0.84
Properties of a lectin purified from the seeds of Cicer arietinum. Hoppe Seylers Z Physiol Chem (1983) 0.84
Human IgG isotype-specific amino acid residues affecting complement-mediated cell lysis and phagocytosis. Eur J Immunol (1994) 0.84
Isolation and characterization of IgG subclass proteins and Fc fragments from normal human IgG. A method for utilizing 'non a' and 'non g' as genetic markers. Immunochemistry (1971) 0.84
Mannose-binding lectin and meningococcal disease. Lancet (1999) 0.84
Conformation of the hinge region and various fragments of human IgG3. Scand J Immunol (1975) 0.83
In situ two- and three-color immunofluorescence staining of mucosal T-cells in celiac disease. Increase of TCR gamma/delta+CD8- and TCR alpha/beta+CD45R0+ intraepithelial lymphocytes and IL-2R+ TCR alpha/beta+CD4+CD45R0+ lamina propria lymphocytes. Prog Histochem Cytochem (1992) 0.82
Human IgG subclass-specific rabbit antisera suitable for immunoprecipitation in gel, ELISA and multilayer haemagglutination techniques. J Immunol Methods (1985) 0.82
Functional activities and immunoglobulin variable regions of human and murine monoclonal antibodies specific for the P1.7 PorA protein loop of Neisseria meningitidis. Infect Immun (2000) 0.82
Streptolysin O neutralizing capacity and idiotypic properties of fragments, subunits and reassociated H and L chains from three human IgG monoclonal proteins. Mol Immunol (1980) 0.82
IgG subclass antibody responses to pneumococcal polysaccharide vaccine in splenectomized, otherwise normal, individuals. Scand J Immunol (1990) 0.82
Monoclonal IgM with lupus anticoagulant activity in a case of Waldenström's macroglobulinaemia. Eur J Haematol (1987) 0.82
Different glycosylation pattern of human IgG1 and IgG3 antibodies isolated from transiently as well as permanently transfected cell lines. Scand J Immunol (2013) 0.81
Streptococcus pneumoniae heat shock protein 70 does not induce human antibody responses during infection. FEMS Immunol Med Microbiol (2000) 0.81
Anti-VH antibodies interfere with antigen binding by human T lymphocytes. Clin Exp Immunol (1982) 0.81
Protective effect of Plantago major L. Pectin polysaccharide against systemic Streptococcus pneumoniae infection in mice. Scand J Immunol (2000) 0.81
Restriction of human immune antibodies to heavy-chain variable subgroups. Scand J Immunol (1976) 0.81
Neutralizing human antibodies to varicella-zoster virus (VZV) derived from a VZV patient recombinant antibody library. J Gen Virol (2004) 0.81
The amino acid sequence of a human immunoglobulin G3m(g) pFc' fragment. J Immunol (1977) 0.80
Epitope analyses of pneumococcal surface protein A: a combination of two monoclonal antibodies detects 94% of clinical isolates. FEMS Immunol Med Microbiol (2001) 0.80
Immune responses to linear epitopes on the PorB protein of Neisseria meningitidis in patients with systemic meningococcal disease. Microbiology (1996) 0.80
Characterization of an FcgammaRI-binding peptide selected by phage display. Protein Eng Des Sel (2006) 0.80
Selection and characterization of cyclic peptides that bind to a monoclonal antibody against meningococcal L3,7,9 lipopolysaccharides. Scand J Immunol (2004) 0.80
Evidence for recent duplications among certain gamma globulin heavy chain genes. J Exp Med (1971) 0.80
The extended hinge region of IgG3 is not required for high phagocytic capacity mediated by Fc gamma receptors, but the heavy chains must be disulfide bonded. Eur J Immunol (1993) 0.79